Contact The Organon Access Program Mon-Fri, 8 AM-8 PM ET, at 1-866-809-9515.

The Organon Co-pay Assistance Program

The Organon Co-pay Assistance Program offers assistance to eligible patients who need help affording their medication.
  • Once enrolled, eligible, privately insured patients may pay as little as $0 per prescription and/or administration of their medication.
  • Co-pay assistance from the Organon Co-pay Assistance Program is not insurance. Restrictions apply. See Terms and Conditions.
  • Not all support services are available for every product. Please see the specific Product Resource page for more information.
Go to Co-pay Assistance Portal
CO-PAY ASSISTANCE MAY BE AVAILABLE FOR PATIENTS WHO:
  • Are a resident of the United States
  • Have private health insurance that provides coverage for their medication
  • Have been prescribed their medication for an FDA-approved indication
  • Meet all other Terms and Conditions of the program

The Organon Co-pay Assistance Program is not valid for patients covered under a government program, as that term is defined in the Terms and Conditions. The Organon Co-pay Assistance Program is not valid for uninsured patients.

Patients and health care professionals must submit all required information. Please see the enrollment form for details.

Other financial support options

What if my patient is not eligible for the Organon Co-pay Assistance Program?

You may be able to get help from an independent co-pay assistance foundation. A representative can provide you with information about independent foundations that may be able to provide financial support to patients who do not qualify for the Organon Co-pay Assistance Program. Each independent foundation has its own eligibility criteria and application process.

Click on the Medication Below for Information or to Enroll:

BILDYOS

BILDYOS®

(denosumab-nxxp) injection 60 mg/mL
Before prescribing BILDYOS, please read the Prescribing Information, including the Boxed Warning. The Medication Guide also is available.
BILPREVDA

BILPREVDA®

(denosumab-nxxp) injection 120 mg/1.7 mL
Before prescribing BILPREVDA, please read the Prescribing Information.
HADLIMA

HADLIMA®

(adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL 
Before prescribing HADLIMA, please read the Prescribing Information, including the Boxed Warning. The Medication Guide and Instructions for Use also are available.
NEXPLANON

NEXPLANON®

(etonogestrel implant) 68 mg Radiopaque
Before prescribing NEXPLANON, please read the Prescribing Information, including the Boxed Warning.
ONTRUZANT

ONTRUZANT®

(trastuzumab-dttb) for injection, for intravenous use 21 mg/mL
Before prescribing ONTRUZANT, please read the Prescribing Information, including the Boxed Warning.
RENFLEXIS

RENFLEXIS®

(infliximab-abda) for injection, for intravenous use 100 mg
Before prescribing RENFLEXIS, please read the Prescribing Information, including the Boxed Warning. The Medication Guide also is available.
TOFIDENCE

TOFIDENCE®

(tocilizumab-bavi) injection, for intravenous use
Before prescribing TOFIDENCE, please read the Prescribing Information, including the Boxed Warning. The Medication Guide also is available.